HU9700274D0 - (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion - Google Patents

(-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion

Info

Publication number
HU9700274D0
HU9700274D0 HU9700274A HUP9700274A HU9700274D0 HU 9700274 D0 HU9700274 D0 HU 9700274D0 HU 9700274 A HU9700274 A HU 9700274A HU P9700274 A HUP9700274 A HU P9700274A HU 9700274 D0 HU9700274 D0 HU 9700274D0
Authority
HU
Hungary
Prior art keywords
celle
piperazin
phenoxy
pyridyl
inhibitor
Prior art date
Application number
HU9700274A
Other languages
Hungarian (hu)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HU9700274D0 publication Critical patent/HU9700274D0/en
Publication of HUP9700274A2 publication Critical patent/HUP9700274A2/en
Publication of HUP9700274A3 publication Critical patent/HUP9700274A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9700274A 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound HUP9700274A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (3)

Publication Number Publication Date
HU9700274D0 true HU9700274D0 (en) 1997-04-28
HUP9700274A2 HUP9700274A2 (en) 1999-06-28
HUP9700274A3 HUP9700274A3 (en) 2000-02-28

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700274A HUP9700274A3 (en) 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB9406143D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic derivatives
CA2155307A1 (en) * 1993-03-29 1994-10-13 Michael Garth Wayne Heterocyclic compounds as platelet aggregation inhibitors

Also Published As

Publication number Publication date
AT406675B (en) 2000-07-25
EP0796247A1 (en) 1997-09-24
WO1996038416A1 (en) 1996-12-05
GB9627127D0 (en) 1997-02-19
BE1009520A5 (en) 1997-04-01
ATA900596A (en) 1999-12-15
CZ26997A3 (en) 1997-08-13
SK13097A3 (en) 1997-08-06
NO970437D0 (en) 1997-01-31
NO307460B1 (en) 2000-04-10
FI970393A0 (en) 1997-01-30
JP2885941B2 (en) 1999-04-26
GR1002702B (en) 1997-05-22
CH691808A5 (en) 2001-10-31
TR199700020T1 (en) 1997-04-22
KR970704689A (en) 1997-09-06
MX9700379A (en) 1997-04-30
BR9606409A (en) 1997-09-30
PL318440A1 (en) 1997-06-09
GB2304340B (en) 1998-07-29
CA2194397A1 (en) 1996-12-05
IL118477A0 (en) 1996-09-12
IE960405A1 (en) 1996-12-11
HUP9700274A3 (en) 2000-02-28
ES2137886B1 (en) 2000-08-16
KR100245957B1 (en) 2000-04-01
LU90008B1 (en) 1997-04-16
DE19680509T1 (en) 1997-12-04
SE510812C2 (en) 1999-06-28
DK10697A (en) 1997-04-01
SE9700203L (en) 1997-01-24
FI970393A (en) 1997-01-30
ITMI961113A1 (en) 1997-12-01
SE9700203D0 (en) 1997-01-24
GB2304340A (en) 1997-03-19
ES2137886A1 (en) 1999-12-16
NZ308597A (en) 1998-11-25
AU710105B2 (en) 1999-09-16
ITMI961113A0 (en) 1996-05-31
NO970437L (en) 1997-02-20
NL1003243C2 (en) 1996-12-04
MC2418A1 (en) 1997-05-23
JPH09512836A (en) 1997-12-22
AU5827296A (en) 1996-12-18
HUP9700274A2 (en) 1999-06-28
IT1290839B1 (en) 1998-12-14

Similar Documents

Publication Publication Date Title
HUP0103160A3 (en) Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitor
AU7177296A (en) Crystalline hydrochloride of (R)-(-)-2-N-(4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl)- aminomethyl-chroman
WO1999005096A3 (en) Urokinase inhibitors
CZ20011657A3 (en) Novel piperazine and piperidine compounds; process of their preparation and use
NZ299788A (en) 4-substituted(4-(1-adamantyl)phenyl) derivatives
CA2347117A1 (en) Methods for inhibiting diabetic complications
HU9700274D0 (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion
HUP9800511A3 (en) Phosphorylized derivatives of 4-{4-[4-(hydroxy-diphenyl)-1-pipe
DE60001599T2 (en) Process for the preparation of cis-1-2- [4- (6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl) phenoxy] ethyl pyrrolidine
HUP9901751A3 (en) Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
AU2034601A (en) Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
EP1181954A3 (en) Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (ApoB) secretion
PL343705A1 (en) Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine
CA2356240A1 (en) Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
AU4595100A (en) ((e),3(r))-enantiomer of 4-(3-chloro -4-cyanophenyl) -1-(p- methylsulphonyl -phenylsulphonyl) -2-trifluoromethylbut -trans-3-en-ol
IL126745A0 (en) Improved methods of preparing 4-cyano-4-(substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
ZA952815B (en) Novel crystal forms of 1-(5-methanesulfonamidoindolyl-2-carbonyl)-4-(3-(1-methylethylamino)-2-pyridinyl) piperazine
FR2734818B1 (en) (-) - (3R) -3-METHYL-4- {4- [4- (4-PYRIDYL) PIPERAZINE-1-YL- PHENOXY} -BUTYRIC ACID, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
PL313359A1 (en) Method of obtaining 1-{4-[2-(2-methoxy-5-chlorobenzamido)-ethyl]-benzosulphonyl}-3-cyclohexylurea
HUT75044A (en) Process and diastereomeric salts useful for the optical resolution of racemic alpha-[4-(1,1-dimethylethyl)-phenyl]4-(hydroxydiphenylmethyl)-1-piperidinebutanol and derivative compounds
AU2002233805A1 (en) Process for preparing 2-(4-chlorobenzolamino) -3-(2(1h) -quinolinon-4-yl)proprionic acid
HU9603414D0 (en) 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
SI0888336T1 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases